SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Contreras Jaime

(Last) (First) (Middle)
100 ABBOTT PARK ROAD

(Street)
ABBOTT PARK IL 60064

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
3. Date of Earliest Transaction (Month/Day/Year)
01/30/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common shares without par value 01/30/2019 M 46,017 A $44.4 100,985 D
Common shares without par value 01/30/2019 M 84,169 A $38.4 185,154 D
Common shares without par value 01/30/2019 M 83,951 A $47 269,105 D
Common shares without par value 01/30/2019 S 177,457 D $70 91,648 D
Common shares without par value 01/31/2019 M 62,600 A $47 154,248 D
Common shares without par value 01/31/2019 M 77,550 A $38.4 231,798 D
Common shares without par value 01/31/2019 F 108,090 D $71.68 111,301(1) D
Common shares without par value 22(2) I Profit Sharing Trust
Common shares without par value 84,579(3) I Jaime Contreras Marvan 2006 Living Trust
Common shares without par value 2,595(4) I By Spouse
Common shares without par value 12,081(5) I Living Trust (by spouse)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)(6) $44.4 01/30/2019 M 46,017 02/17/2018 02/16/2027 Common Shares 46,017 $0 92,032 D
Option (right to buy)(6) $38.4 01/30/2019 M 84,169 02/19/2017 02/18/2026 Common Shares 84,169 $0 158,410 D
Option (right to buy)(6) $47 01/30/2019 M 83,951 02/20/2016 02/19/2025 Common Shares 83,951 $0 62,600 D
Option (right to buy)(6) $47 01/31/2019 M 62,600 02/20/2018 02/19/2025 Common Shares 62,600 $0 0 D
Option (right to buy)(6) $38.4 01/31/2019 M 77,550 02/19/2018 02/18/2026 Common Shares 77,550 $0 80,860 D
Explanation of Responses:
1. Excludes 12,407 shares previously directly owned which were transferred to the Jaime Contreras Marvan 2006 Living Trust on September 21, 2018.
2. Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2019.
3. Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
4. The reporting person disclaims beneficial ownership of all securities held by his spouse.
5. Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
6. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks:
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Jessica H. Paik, by power of attorney for Jaime Contreras 02/01/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Exhibit 24.1


POWER OF ATTORNEY


The undersigned constitutes and appoints HUBERT L. ALLEN, JESSICA
H. PAIK, and AARON N. RICE, and each of them individually, as the
undersigned's true and lawful attorney-in-fact and agent, with
full power of substitution and re-substitution, for the
undersigned and in the undersigned's name, place and stead, 
to prepare and sign any and all Securities and Exchange Commission
("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144
under the Securities Act of 1933 on Form 144, all SEC statements
on Forms 3, 4 and 5 as required under Section 16(a) of the Securities
Exchange Act of 1934, including a Form ID and any other documents
necessary to obtain codes and passwords necessary to make electronic 
filings, and any amendments to such forms, and to file the same with
all exhibits thereto, and other documents in connection therewith,
with the SEC, granting unto said attorney-in-fact and agent full 
power and authority to do and perform each act and thing requisite, 
necessary or desirable to be done under said Rule 144 and Section
16(a), as fully for all intents and purposes as the undersigned 
might or could do in person, hereby ratifying and confirming all
that said attorney-in-fact and agent
 may lawfully do or cause to be
done by virtue hereof.

A copy of this power of attorney shall be filed with the SEC.  The
authorization set forth above shall continue in full force and effect
until the undersigned is no longer required to file Forms 144, 3, 4, or
5 or if earlier, until the undersigned revokes such authorization by 
written instructions to the attorney-in-fact.



Date:  December 14, 2018

/s/ Jaime Contreras	             
Signature of Reporting Person

Jaime Contreras


Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064